| Effectiveness of antiemetic regimens for highly emetogenic chemotherapy‐induced nausea and vomiting: a systematic review and network meta‐analysis T Yokoe, T Hayashida, A Nagayama, A Nakashoji, H Maeda, T Seki, ... The oncologist 24 (6), e347-e357, 2019 | 65 | 2019 |
| Genomic profiling reveals heterogeneous populations of ductal carcinoma in situ of the breast S Nagasawa, Y Kuze, I Maeda, Y Kojima, A Motoyoshi, T Onishi, T Iwatani, ... Communications biology 4 (1), 438, 2021 | 42 | 2021 |
| Cystoid macular edema during treatment with paclitaxel and bevacizumab in a patient with metastatic breast cancer: a case report and literature review T Yokoe, I Fukada, K Kobayashi, T Shibayama, Y Miyagi, A Yoshida, ... Case Reports in Oncology 10 (2), 605-612, 2017 | 34 | 2017 |
| The updated network meta-analysis of neoadjuvant therapy for HER2-positive breast cancer A Nakashoji, T Hayashida, T Yokoe, H Maeda, T Toyota, M Kikuchi, ... Cancer Treatment Reviews 62, 9-17, 2018 | 28 | 2018 |
| IgG4‐related mastopathy: a case report and literature review T Yokoe, T Hayashida, M Kikuchi, R Watanuki, A Nakashoji, H Maeda, ... Clinical Case Reports 6 (8), 1549, 2018 | 20 | 2018 |
| Clinical benefit of treatment after trastuzumab emtansine for HER2-positive metastatic breast cancer: a real-world multi-centre cohort study in Japan (WJOG12519B) T Yokoe, S Kurozumi, K Nozawa, Y Ozaki, T Maeda, S Yazaki, M Onishi, ... Breast Cancer 28, 581-591, 2021 | 16 | 2021 |
| Establishment of a deep‐learning system to diagnose BI‐RADS4a or higher using breast ultrasound for clinical application T Hayashida, E Odani, M Kikuchi, A Nagayama, T Seki, M Takahashi, ... Cancer science 113 (10), 3528-3534, 2022 | 10 | 2022 |
| MiR-181a targets STING to drive PARP inhibitor resistance in BRCA- mutated triple-negative breast cancer and ovarian cancer MA Bustos, T Yokoe, Y Shoji, Y Kobayashi, S Mizuno, T Murakami, ... Cell & Bioscience 13 (1), 200, 2023 | 8 | 2023 |
| UBQLN4 promotes STING proteasomal degradation during cisplatin‐induced DNA damage in triple‐negative breast cancer Y Shoji, T Yokoe, Y Kobayashi, T Murakami, PJ Bostick, Y Shiloh, ... Clinical and translational medicine 12 (7), 2022 | 8 | 2022 |
| Avoidance and period-shortening of neoadjuvant chemotherapy against triple-negative breast cancer in stages I and II: importance of Ki-67 labeling index and the recognition of … K Kubouchi, K Shimada, T Yokoe, Y Tsutsumi Technology in Cancer Research & Treatment 19, 1533033820943246, 2020 | 7 | 2020 |
| Optimal use of anthracycline-free perioperative chemotherapy in HER2-positive breast cancer patients R Watanuki, T Hayashida, Y Kawai, M Kikuchi, A Nakashoji, T Yokoe, ... International Journal of Clinical Oncology 24, 807-814, 2019 | 7 | 2019 |
| Genomic profiling reveals heterogeneous populations of ductal carcinoma in situ of the breast. Commun Biol 4 (1): 438 S Nagasawa, Y Kuze, I Maeda, Y Kojima, A Motoyoshi, T Onishi, T Iwatani, ... | 6 | 2021 |
| Impact of neoadjuvant and adjuvant chemotherapy on invasive lobular carcinoma: a propensity score‐matched analysis of SEER data R Watanuki, T Hayashida, T Yokoe, Y Kawai, M Kikuchi, A Nakashoji, ... The Breast Journal 26 (9), 1765-1770, 2020 | 6 | 2020 |
| Increased frequency of ESR1 mutation in metastatic breast cancer by dosing selective estrogen receptor modulator followed by aromatase inhibitor K Takeshima, T Hayashida, H Maeda, A Nakashoji, T Yokoe, T Seki, ... Oncology letters 20 (2), 1231-1238, 2020 | 6 | 2020 |
| Comprehensive analysis of the homeobox family genes in breast cancer demonstrates their similar roles in cancer and development A Nakashoji, T Hayashida, S Yamaguchi, Y Kawai, M Kikuchi, T Yokoe, ... Breast Cancer Research and Treatment 186, 353-361, 2021 | 5 | 2021 |
| Predictors of invasive disease in patients preoperatively diagnosed with ductal carcinoma without stromal invasion, with breast magnetic resonance imaging (MRI) and ultrasound (US) H Maeda, T Hayashida, R Watanuki, M Kikuchi, A Nakashoji, T Yokoe, ... Breast Cancer 28, 398-404, 2021 | 5 | 2021 |
| Multicentre, randomised, double-blind, placebo-controlled phase II study of prophylactic olanzapine for patients with metastatic breast cancer receiving T-DXd treatment … H Sakai, J Tsurutani, Y Ozaki, H Ishiguro, K Nozawa, K Watanabe, ... BMJ open 13 (4), e070304, 2023 | 3 | 2023 |
| Heterochronous suture line recurrences in the Jejunal Pouch following total gastrectomy for stage II gastric cancer: a case report and literature review T Yokoe, M Sato, M Yahagi, M Dogru, H Fujisaki, M Ogura, H Kawamata, ... Case reports in oncology 13 (1), 225-232, 2020 | 3 | 2020 |
| Identification of a Modified HOXB9 mRNA in Breast Cancer A Nakashoji, T Hayashida, Y Kawai, M Kikuchi, R Watanuki, T Yokoe, ... Journal of Oncology 2020 (1), 6065736, 2020 | 2 | 2020 |
| 尿路変向を伴う泌尿器科術後に尿管が原因となって内ヘルニアを来した 1 例 松岡信成， 石田隆， 岡林剛史， 鶴田雅士， 横江隆道， 前田祐助， 蛭川和也， ... 日本消化器外科学会雑誌 52 (10), 605-610, 2019 | 1 | 2019 |
